this study was designed to evaluate the efficacy and tolerability of recombinant leukocyte interferon alfa-2a ( hoffmann-laroche ) as single agent in patients with histologically confirmed mycosis fungoides .
C0021734
recombinant
C0026948
mycosis fungoides